Kentucky Retirement Systems Insurance Trust Fund Purchases 6,934 Shares of Colgate-Palmolive (NYSE:CL)

Kentucky Retirement Systems Insurance Trust Fund increased its position in Colgate-Palmolive (NYSE:CL) by 28.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,126 shares of the company’s stock after acquiring an additional 6,934 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Colgate-Palmolive were worth $2,830,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of CL. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $32,000. Hager Investment Management Services LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at approximately $36,000. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Roxbury Financial LLC purchased a new stake in Colgate-Palmolive during the 4th quarter valued at $43,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the third quarter valued at $53,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $86.10 on Tuesday. The stock has a market cap of $70.34 billion, a PE ratio of 24.46, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. The business has a fifty day simple moving average of $89.53 and a 200-day simple moving average of $96.33. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12 month low of $83.20 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the business earned $0.87 earnings per share. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CL shares. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Raymond James restated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Piper Sandler lowered their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. TD Cowen lowered their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Finally, Barclays lowered their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.